2004
DOI: 10.2165/00063030-200418010-00004
|View full text |Cite
|
Sign up to set email alerts
|

A Multi-Model Approach to Nucleic Acid-Based Drug Development

Abstract: With the advent of functional genomics and the shift of interest towards sequence-based therapeutics, the past decades have witnessed intense research efforts on nucleic acid-mediated gene regulation technologies. Today, RNA interference is emerging as a groundbreaking discovery, holding promise for development of genetic modulators of unprecedented potency. Twenty-five years after the discovery of antisense RNA and ribozymes, gene control therapeutics are still facing developmental difficulties, with only one… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2004
2004
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 200 publications
0
4
0
Order By: Relevance
“…The past decade has seen an upsurge of interest in nucleic acid-based drug development. 254 This is mainly due to the realization that modified oligomers (oligos), with improved properties, can be used in the sequence specific control of gene expression and have immense potential as therapeutic agents. 236,[255][256][257][258][259] A principle mode of action of these modified oligos is through binding to a specific mRNA sequence associated with a disease and thereby (a) terminating the translation of a defective protein (antisense) 236,255,257 or (b) altering splice sites.…”
Section: Oligonucleoside Boranophosphatesmentioning
confidence: 99%
“…The past decade has seen an upsurge of interest in nucleic acid-based drug development. 254 This is mainly due to the realization that modified oligomers (oligos), with improved properties, can be used in the sequence specific control of gene expression and have immense potential as therapeutic agents. 236,[255][256][257][258][259] A principle mode of action of these modified oligos is through binding to a specific mRNA sequence associated with a disease and thereby (a) terminating the translation of a defective protein (antisense) 236,255,257 or (b) altering splice sites.…”
Section: Oligonucleoside Boranophosphatesmentioning
confidence: 99%
“…For details the interested reader is referred to the reviews by Sohail & Southern 4 and Gautherot & Sodoyer. 5 To identify accessible target sites on a complex and highly structured RNA by any of these methods is a time and labour consuming process that does not always meet with success. In general, only one out of eight antisense oligonucleotides is thought to be efficient for knockdown of target genes.…”
Section: Introductionmentioning
confidence: 99%
“…Detection of single nucleotide polymorphisms and point mutations is difficult and sometimes impossible if the underlying sequence is inaccessible to hybridization. Since RNA folding programs based on nearest-neighbor thermodynamic parameters are not totally reliable for long transcripts ( ), sequences that are available for hybridization must be determined experimentally for each RNA. Several strategies have been described that lessen the interference due to secondary structures.…”
mentioning
confidence: 99%